These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29243738)

  • 1. Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study.
    Sharma SG; Larsen CP
    Mod Pathol; 2018 Apr; 31(4):616-622. PubMed ID: 29243738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
    Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
    Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
    J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
    Tian C; Li L; Liu T; Qu X; Qiu Y
    Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
    von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
    Front Immunol; 2018; 9():3035. PubMed ID: 30619370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy.
    Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E
    Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans.
    Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG
    BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
    Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
    Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
    Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
    Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
    Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
    N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous Remission of Thrombospondin Type-1 Domain-Containing-Associated Membranous Nephropathy.
    Watanabe S; Suzuki T; Han W; Nakata M; Koitabashi K; Ichikawa D; Kamijo-Ikemori A; Koike J; Shibagaki Y
    Intern Med; 2021 Oct; 60(19):3125-3128. PubMed ID: 33840692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
    Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.
    Larsen CP; Cossey LN; Beck LH
    Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
    Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
    J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
    Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
    J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
    Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
    Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
    Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
    Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.
    Dettmar AK; Wiech T; Kemper MJ; Soave A; Rink M; Oh J; Stahl RAK; Hoxha E;
    Pediatr Nephrol; 2018 Mar; 33(3):463-472. PubMed ID: 29034405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
    Weinmann-Menke J; Holtz S; Sollinger D; Dörken M; Boedecker S; Schamberger B; Pfister F; Amann K; Lutz J
    Am J Kidney Dis; 2019 Dec; 74(6):849-852. PubMed ID: 31451329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.